Stock OBS ORBIS AG
Add to a list
To use this feature you must be a member
Log inSign up

News ORBIS AG

Equities

OBS

DE0005228779

Market Closed - Xetra
Other stock markets
 11:36:00 2024-04-19 am EDT 		5-day change 1st Jan Change
5.9 EUR -0.84% Intraday chart for ORBIS AG -0.84% +3.51%
Mar. 27 ORBIS AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 01 Donald Trump's lawsuit over 'Steele dossier' thrown out by UK court RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AGITATED SOLUTIONS RECEIVES HEALTH CANADA LICENSE FOR ORBIS MICROBUBBLE GENERATOR TO STREAMLINE CARDIAC BUBBLE STUDIES
AQ
New VR Solution to Democratize Ophthalmic Surgical Training: Affordable, Portable and Scalable
AQ
ORBIS : Profitable growth in financial year 2023
PU
ORBIS AG Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ORBIS SE founds new subsidiary ORBIS Value Plus: Digital process transformation for business value optimization
PU
Trump is ordered to pay legal fees after failed lawsuit over the Steele dossier
AQ
UK judge dismisses Trump's lawsuit over dossier containing 'shocking and scandalous claims'
AQ
Donald Trump's lawsuit over 'Steele dossier' thrown out by UK court
RE
AFR: ORBIS SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
Blinding Injustice: Trachoma Takes Unequal Toll on Women
AQ
It's Time to Give a Cr*p About Trachoma!
AQ
Pola Orbis Plans New Subsidiary in China
MT
Trump committed egregious intelligence breach, ex-UK spy tells court
RE
Donald Trump's lawsuit over 'Steele dossier' in London court
RE
Pola Orbis Holdings' Creates New Subsidiary Pola Medical to Expand its Presence in Aesthetic Medicine Field
MT
ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2023
CI
ORBIS : with positive business development in the first half of 2023
PU
Cartel Intel – Ninth Edition Now Available Giving A Consolidated View Of Key Cartel Developments Across EMEA
AQ
Consolidation to boost value of Japan's still fragmented drugstore sector - Orbis
RE
AstraZeneca Says New Drug Application for Breast Cancer Combination Therapy Granted Priority Review by US FDA
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OBS Stock
  4. News ORBIS AG